学院
大会日程

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: Explain the difference between exosomes and hybrosomes
Introduce new concepts of hybrosomes and autogenous exosomes

Introduction: New concepts in regenerative medicine are evolving at a rapid rate. The most important aspect of this emerging field is to provide data as different sources of exosomes produce vastly different products and almost none of them have provided strong data as to both their efficacy and relative benefits (ie some products are definitely better than others). Herein, we describe two new concepts that improve both efficacy and ease of delivery: hybrasomes and autogenous exosomes.

Materials / method: Data from large clinical studies will be reported for hybrosomes and preliminary clinical data as well as scientific foundations will be presented for autogenous exosomes.

Results: Hybrosomes are much more powerful in terms of wound healing, reducing inflammation and regenerating tissue than exosomes alone.
Autogenous exosomes demonstrate unique benefits in composition, ease of use and regenerative capacity both in laboratory studies and in early clinical results.

Conclusion: New concepts in regenerative medicine demonstrate improved efficacy in large clinical trials of hybrosomes. Autogenous exosomes permit any practioner who is using PRP to use more effective regenerative products as both an injection as well as a filler.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: Mage Biotechnology

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。